identification by mass spectrometry (MS) of biomarkers from serum and/or plasma. We
consider the effects of the variables involved in sample collection, handling and storage, and
describe different approaches for removal of high abundance proteins and serum/plasma
fractionation. We review the advantages and disadvantages of such techniques as
centrifugal ultrafiltration, different formats for solid phase extraction, organic solvent …